- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Arena Pharmaceuticals Inc+ Add to Watchlist
RN3:GR2.974 EUR 0.159 5.08%
As of 15:17:41 ET on 12/23/2014.
Company Profile for Arena Pharmaceuticals Inc (RN3)
Arena Pharmaceuticals, Inc. is a biotechnology company that has developed a receptor-based screening assay using their own CART technology.
Arena Pharmaceuticals Inc
Key Executives for Arena Pharmaceuticals Inc (RN3)
|Jack LiefChairman/Pres/CEO/Co-Founder||Dominic P BehanExec VP/Chief Scientific Ofcr|
|Steven W SpectorExec VP/General Counsel/Secy||Robert E HoffmanSenior VP:Finance/CFO|
|William R Shanahan JrSenior VP/Chief Medical Ofcr||Craig M AudetSenior VP:Operations/Head:Global|
|Cindy McGeeVP:Investor Relations|